What is this leadership forum?
- The RWE Leadership Forum is a group of senior RWE executives across major pharma companies, supported and facilitated by IQVIA. This group works as a non-compete collaborative to understand, discuss and respond to internal and external RWE challenges and opportunities with a single expert voice, with the aim of improving outcomes for patients globally.
- One of the top priorities of the RWE Leadership Forum is to clarify the way pharma and healthcare can work together to establish trust-based relationships, which will unlock unique value for society, the medical community and patients. The forum meets twice a year to discuss issues facing RWE in the industry and develop an aligned positioning.
- Several working groups are maintained throughout the year to dive deeper into priorities decided on by the forum. These working groups will produce whitepapers, publications, frameworks, and info graphics tackling RWE topics decided on by the forum.
Forum publications and resources
Strengthening Pharma’s Contract With Society: The Value of Trusted Partnerships Between Pharma and Healthcare Facilitated By Real-world Data
How pharma can build trusted relationships around a common purpose and the role real world data plays in establishing those collaborations.
Bridging the gap between RCTs and RWE through endpoint selection
The value in bridging the industry disconnect between RTCs and RWE, with a view to promoting the use of RWE in the RCT environment, has recently been published in Therapeutic Innovations & Regulatory Science.
The state of play in RWE
Key aggregated findings from a benchmarking survey of RWE capabilities across 9 global biopharma companies.
Current working groups and priority topics
Measuring the return on investment & impact of RWE
Objective: Create a common framework for discussing the value and impact of RWE and to quantify the benefits/risks of conducting RWE studies.
Supporting internal leadership in making informed investment prioritisation decisions, and drive the routine adoption of RWE
Improving patient trust in RWE
Objective: To improve patient understanding of Real World Data and Real World Evidence.
To build patient trust and understanding of the value of sharing healthcare data.
To improve access to patient level data for use in research.
Transforming Uses of RWE and Capabilities
Objective: Identify the organisational capabilities required for successful implementation and use of ‘transformational RWE’
Assess capabilities for their suitability to be kept in-house vs. which could be outsourced
Define overarching governance principles that drive RWE alignment across the organisation
RWE for Payers and Regulators
Objective: Addressing the receptivity of RWE with both payers and regulators
Investigate the different ways in which stakeholders are using RWE, building the credibility of RWE and how it can support a full body of evidence.
The forum is supported by IQVIA's Integrated Real World Evidence & Solutions team.
For any enquiries please contact James Charnock.
Copyright © 2024 IQVIA Holdings Inc. and its affiliates. All rights reserved. Privacy Statement
